PetDx: Funding, Investors & Team (Oct 2026)
PetDx® – The Liquid Biopsy Company for Pets is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company's flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, empowering veterinarians to provide superior care to canine patients.
PetDx has raised $62.0M across 1 funding round on record, the most recent a Series B of $62.0M announced in Dec 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PetDx Company Profile and Key Stats
Latest funding round on record: Dec 2021.
PetDx Funding Rounds
PetDx Founders and Leadership Team
Contact details for the PetDx team: 1 of 1 has an email address on file.
Start 14-day free trial →PetDx Funding Compared to Other Biotechnology Startups
PetDx's latest round of $62.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PetDx in Biotechnology and La Jolla
Companies Similar to PetDx
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
PetDx Funding FAQs
What does PetDx do?
PetDx® – The Liquid Biopsy Company for Pets is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company's flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, empowering veterinarians to provide superior care to canine patients.
How much funding has PetDx raised?
PetDx has raised $62.0M across 1 round on record. The most recent is a Series B of $62.0M announced in Dec 2021.
When did PetDx last raise funding?
PetDx's most recent funding round on record is a Series B of $62.0M, announced in Dec 2021.
Who is the CEO of PetDx?
Daniel Grosu is listed as CEO at PetDx.
Where is PetDx headquartered?
PetDx is based in La Jolla, California, United States.
How many employees does PetDx have?
PetDx is in the 51-100 employee band.
How does PetDx's funding compare to other Biotechnology startups?
PetDx's latest round of $62.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's PetDx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PetDx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.